this post was submitted on 31 Oct 2026
167 points (100.0% liked)

Technology

89311 readers
3234 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots


founded 3 years ago
MODERATORS
 

The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

you are viewing a single comment's thread
view the rest of the comments
[–] Juviz@lemmy.zip 1 points 19 hours ago* (last edited 19 hours ago)

While you are right in principle, what you are quoting is exactly what I was talking about. The cancer that was introduced to those mice was known beforehand and the vaccine adapted to it. Similar treatments have been available for melanoma for a few years. It’s actually insane considering how much of a death sentence skin cancer was when I was in med school 12 years ago.

However this is a case of similar antigens in different cancers. This is sadly not the norm. While this might have some effect in this very controlled experiment, a general vaccine is unlikely. We might be able to get immunization for specific cancer subtypes, what is nor likely though, is that we do molecular testing on a tumor and then apply targeted therapy as a vaccine.

We have a molecular tumor conference at our university where we apply exactly these principles. It’s a very exciting time and I see my future as a oncological surgeon somewhat endangered, however this type of treatment will still need decades to be brought to mainstream and most likely be extremely expensive in the beginning

Edit: I reread the whole article after my reply, it was not a case of cross tumor antigens, it was two different vehicles for different cancers, one melanoma, one colonic cancer. So no vaccine in the typical sense